Need help choosing the right code?
Ask CasePilot about procedures, modifiers, bundling, and coding guidance.
Try CasePilot© Copyright 2026 American Medical Association. All rights reserved.
The CPT® Code 80166 refers to a laboratory test specifically designed to measure the levels of doxepin in the blood. Doxepin, which is also known by its brand name Sinequan, is classified as a tricyclic antidepressant. It is primarily utilized in the treatment of various mental health conditions, including depression and anxiety disorders. The test is crucial for monitoring the therapeutic levels of doxepin, which are defined as being between 100 to 300 ng/ml. Levels exceeding 500 ng/ml are considered toxic and may lead to adverse effects. Symptoms associated with doxepin toxicity can manifest as anticholinergic effects, which include flushing, dry skin, dry mucous membranes, urinary retention, and an increased heart rate, known as tachycardia. To accurately assess doxepin levels, a blood sample is collected through a procedure known as venipuncture, which is separately reportable. It is important that the blood draw occurs prior to the administration of the drug to ensure that the measurement reflects the trough level of doxepin. The analysis of the serum or plasma is conducted using a sophisticated technique called quantitative liquid chromatography-tandem mass spectrometry, which allows for precise quantification of the drug in the sample.
© Copyright 2026 Coding Ahead. All rights reserved.
The laboratory test for doxepin levels is indicated for the following conditions:
The procedure for obtaining doxepin levels involves several critical steps to ensure accurate results:
After the blood sample has been collected, there are a few considerations for post-procedure care. The site of venipuncture may experience some minor discomfort or bruising, which typically resolves on its own. Patients are generally advised to apply pressure to the site to minimize bleeding and to keep the area clean. Results from the doxepin level test will be analyzed and reported back to the healthcare provider, who will interpret the findings in the context of the patient's treatment plan. If toxic levels are detected, appropriate clinical interventions may be necessary to address the potential side effects associated with elevated doxepin levels.
| Short Descr | ASSAY OF DOXEPIN | Medium Descr | DRUG SCREEN QUANTITATIVE DOXEPIN | Long Descr | Doxepin | Status Code | Statutory Exclusion (from MPFS, may be paid under other methodologies) | Global Days | XXX - Global Concept Does Not Apply | PC/TC Indicator (26, TC) | 9 - Not Applicable | Multiple Procedures (51) | 9 - Concept does not apply. | Bilateral Surgery (50) | 9 - Concept does not apply. | Physician Supervisions | 9 - Concept does not apply. | Assistant Surgeon (80, 82) | 9 - Concept does not apply. | Co-Surgeons (62) | 9 - Concept does not apply. | Team Surgery (66) | 9 - Concept does not apply. | Diagnostic Imaging Family | 99 - Concept Does Not Apply | APC Status Indicator | Items and Services Packaged into APC Rates | Type of Service (TOS) | 5 - Diagnostic Laboratory | Berenson-Eggers TOS (BETOS) | T1H - Lab tests - other (non-Medicare fee schedule) | MUE | Not applicable/unspecified. | CCS Clinical Classification | 235 - Other Laboratory |
Get instant expert-level medical coding assistance.